Literature DB >> 9522853

The management of cryptococcal meningitis in Papua New Guinea.

R A Seaton1.   

Abstract

Cryptococcal meningitis is a difficult disease to treat and requires biochemical and haematological monitoring to detect the common adverse effects of treatment. Combination therapy with amphotericin B and flucytosine for at least 6 weeks is the best treatment so far evaluated. The role of azole drugs should become clearer as the results of large multicentre studies become available in the future. High case fatality and morbidity rates despite standard treatment suggest that other ancillary treatments such as corticosteroids and other treatments directed at lowering raised intracranial pressure may also be required in some patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9522853

Source DB:  PubMed          Journal:  P N G Med J        ISSN: 0031-1480


  4 in total

Review 1.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

2.  The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues.

Authors:  Edmond J Byrnes; Kieren A Marr
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 3.  Adhesins in the virulence of opportunistic fungal pathogens of human.

Authors:  Amrita Kumari; Ankita H Tripathi; Poonam Gautam; Rekha Gahtori; Amit Pande; Yogendra Singh; Taruna Madan; Santosh K Upadhyay
Journal:  Mycology       Date:  2021-07-05

Review 4.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.